text_body: --- DIVISION TITLE ---
  
  Trade Bill - New Clause 17 - UK participation in the European medicines regulatory network
  
  --- MOTION EFFECT ---
  
  
  @ MP voted aye to make retaining membership of the European medicines regulatory network a government objective. 
  @ MP voted no against making retaining membership of the European medicines regulatory network a government objective. 
  
  The majority of MPs voted to make retaining membership of the European medicines regulatory network a government objective. 
  
  MPs were considering the Trade Bill[1].
  
  The proposed new clause accepted in this vote was titled: ''UK participation in the European medicines regulatory network'' and stated:
  
  :(1) It shall be the objective of an appropriate authority to take all necessary steps to implement an international trade agreement, which enables the UK to fully participate after exit day in the European medicines regulatory network partnership between the European Union, European Economic Area and the European Medicines Agency.
  
  :(2) Exit day shall have the meaning set out in section 20 of the European Union (Withdrawal) Act 2018.â
  
  The accepted new clause was accompanied by the following explanatory statement:
  
  :This new clause would ensure that it is a negotiating objective for the UK Government to secure an international agreement through which the UK may continue to participate in the European medicines regulatory network partnership between the EU, EEA and the European Medicines Agency, ensuring that patients continue to have access to high-quality, effective and safe pharmaceutical and medical products, fully aligned with the member states of the EU and EEA.
  
  
  * [1] [https://services.parliament.uk/bills/2017-19/trade.html Parliament's webpage on the Trade Bill]
  
  --- COMMENTS AND NOTES ---
  
  (put thoughts and notes for other researchers here)
  